Sequana Medical Nv Stock Fundamentals
| SEQUA Stock | 0.70 0.03 4.11% |
Sequana Medical NV fundamentals help investors to digest information that contributes to Sequana Medical's financial success or failures. It also enables traders to predict the movement of Sequana Stock. The fundamental analysis module provides a way to measure Sequana Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Sequana Medical stock.
Sequana |
Sequana Medical NV Company Return On Equity Analysis
Sequana Medical's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Sequana Medical Return On Equity | -2.22 |
Most of Sequana Medical's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Sequana Medical NV is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
Based on the latest financial disclosure, Sequana Medical NV has a Return On Equity of -2.2237. This is 90.72% lower than that of the Healthcare sector and 74.53% lower than that of the Medical Devices industry. The return on equity for all Belgium stocks is notably higher than that of the company.
Sequana Medical NV Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Sequana Medical's current stock value. Our valuation model uses many indicators to compare Sequana Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Sequana Medical competition to find correlations between indicators driving Sequana Medical's intrinsic value. More Info.Sequana Medical NV is currently regarded as top stock in return on equity category among its peers. It also is currently regarded as top stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Sequana Medical by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Sequana Medical's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Sequana Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Sequana Medical's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Sequana Medical could also be used in its relative valuation, which is a method of valuing Sequana Medical by comparing valuation metrics of similar companies.Sequana Medical is currently under evaluation in return on equity category among its peers.
Sequana Fundamentals
| Return On Equity | -2.22 | |||
| Return On Asset | -0.54 | |||
| Current Valuation | 134.46 M | |||
| Shares Outstanding | 23.75 M | |||
| Shares Owned By Insiders | 13.66 % | |||
| Shares Owned By Institutions | 53.97 % | |||
| Price To Book | 11.52 X | |||
| Price To Sales | 182.39 X | |||
| Revenue | 370.5 K | |||
| Gross Profit | 718 K | |||
| EBITDA | (22.24 M) | |||
| Net Income | (23.62 M) | |||
| Total Debt | 7.32 M | |||
| Book Value Per Share | 0.55 X | |||
| Cash Flow From Operations | (23.62 M) | |||
| Earnings Per Share | (1.30) X | |||
| Target Price | 12.0 | |||
| Beta | 0.78 | |||
| Market Capitalization | 134.25 M | |||
| Total Asset | 14.71 M | |||
| Z Score | 7.5 | |||
| Net Asset | 14.71 M |
About Sequana Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Sequana Medical NV's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sequana Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sequana Medical NV based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Sequana Medical
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Sequana Medical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sequana Medical will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Sequana Medical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Sequana Medical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Sequana Medical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Sequana Medical NV to buy it.
The correlation of Sequana Medical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Sequana Medical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Sequana Medical NV moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Sequana Medical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Sequana Stock
Sequana Medical financial ratios help investors to determine whether Sequana Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sequana with respect to the benefits of owning Sequana Medical security.